TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2023
Back to search
Official data from USPTO
HANCHORBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HANCHORBIO
ST13
US500000090772551Class
5, 35, 42
Filing
90772551
Registration
6824471
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
01/03/2023
Trademark type
Word
Nice classes
5, 35, 42
Filing date
06/14/2021
Registration date
08/23/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2022
Last transaction
08/23/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
16
Owner location
Taipei City, TW
Examiner
KUYKENDALL, LYNDSEY
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HanchorBio Inc.
Representatives
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products and medicines for the treatment of cancers or autoimmune diseases for human use; Reagents for medical diagnostics; Therapeutic reagents for promoting hair growth; Vaccines for human use; Pharmaceutical reagents for medical useto enhance immunity; Anti-cancer reagents and medicines; Image-forming reagents for medical diagnostics; Western medicines for treating cancers or autoimmune diseases; Chinese medicines for treating cancers or autoimmune diseases; Anti-viral reagents and medicines for treating cancers or autoimmune diseases; Biological reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Protein reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Chemical reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Biological tissue culture reagents for medical therapeutic use for the treatment of cancers or autoimmune diseases; Testing chemicals for medical therapeutic use for the treatment of cancers or autoimmune diseases; Diagnostic reagents for medical therapeutic use; Biomarker diagnostic reagents for medical therapeutic use; Nutritional supplements; Biological reagents for veterinary use
Class 35
retail and wholesale store services featuring pharmaceutical products; retail and wholesale store services featuring western medicines; retail and wholesale store services featuring Chinese medicines; retail and wholesale store services featuring nutritional supplements; retail and wholesale store services featuring medical equipment
Class 42
Providing services for biomedical research and developmentproducing biological medicines; Biological research; Bacteriological research; Providing experimental medicines sample testing and diagnostic services for others for clinical research purposes; Providing reagent sample testing and diagnostic services for others for clinical research purposes; Clinical testing of pharmaceutical medicines for others; Scientific research and analysis of experimental medicines or reagents; Medical research; Product research and development on behalf of other parties; Technical research in the field of pharmaceutical studies; Research for technological programs in the nature of biological drug design; Technical writingwriting of technological documents; industrial analysis and research services; Rental of laboratory equipment for experiments; Service for scientific laboratories; Scientific research; Technological consultancy in the field of biological protein engineering; Scientific research in the field of biological/biomedical protein design and engineering; technical research in the field of biological/biomedical protein design and engineering
Publications
History of USPTO decisions and trademark events.
22 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/23/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/23/2022
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
06/14/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
06/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/07/2022
PUBO
PUBLISHED FOR OPPOSITION
06/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/18/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/07/2022
ALIE
ASSIGNED TO LIE
04/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/08/2022
GNRT
NON-FINAL ACTION E-MAILED
03/08/2022
CNRT
NON-FINAL ACTION WRITTEN
03/08/2022
DOCK
ASSIGNED TO EXAMINER
03/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2021
NWAP
NEW APPLICATION ENTERED
06/17/2021
Continuous trademark protection
Get notified about every new filing that threatens HANCHORBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.